ES549822A0 - Procedimiento para la preparacion de derivados n-acilados del-triptofano - Google Patents

Procedimiento para la preparacion de derivados n-acilados del-triptofano

Info

Publication number
ES549822A0
ES549822A0 ES549822A ES549822A ES549822A0 ES 549822 A0 ES549822 A0 ES 549822A0 ES 549822 A ES549822 A ES 549822A ES 549822 A ES549822 A ES 549822A ES 549822 A0 ES549822 A0 ES 549822A0
Authority
ES
Spain
Prior art keywords
group
substituted
derivatives
meta
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549822A
Other languages
English (en)
Other versions
ES8706630A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rotta Research Laboratorium SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Laboratorium SpA filed Critical Rotta Research Laboratorium SpA
Publication of ES8706630A1 publication Critical patent/ES8706630A1/es
Publication of ES549822A0 publication Critical patent/ES549822A0/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES549822A 1984-12-12 1985-12-11 Procedimiento para la preparacion de derivados n-acilados del-triptofano Expired ES8706630A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT68241/84A IT1179866B (it) 1984-12-12 1984-12-12 Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
ES8706630A1 ES8706630A1 (es) 1987-06-01
ES549822A0 true ES549822A0 (es) 1987-06-01

Family

ID=11308641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549822A Expired ES8706630A1 (es) 1984-12-12 1985-12-11 Procedimiento para la preparacion de derivados n-acilados del-triptofano

Country Status (14)

Country Link
US (1) US4870097A (es)
EP (1) EP0237522B1 (es)
JP (1) JPS62501292A (es)
AT (1) ATE85976T1 (es)
AU (1) AU589938B2 (es)
CA (1) CA1256441A (es)
DE (1) DE3587122T2 (es)
DK (1) DK168564B1 (es)
ES (1) ES8706630A1 (es)
IE (1) IE58502B1 (es)
IT (1) IT1179866B (es)
PT (1) PT81674B (es)
WO (1) WO1986003489A1 (es)
ZA (1) ZA859526B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
US5089638A (en) * 1986-06-16 1992-02-18 Merck & Co., Inc. Amino acid analogs as CCK-antagonists
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
US5360814A (en) * 1991-02-28 1994-11-01 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US5484814A (en) * 1991-02-28 1996-01-16 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
ES2122098T3 (es) * 1991-02-28 1998-12-16 Merrell Pharma Inc Antagonistas del nmda.
US20030199523A1 (en) * 2002-02-28 2003-10-23 Snutch Terrance P. Heterocyclic calcium in channel blockers
EP2311479B1 (en) 2002-09-20 2014-07-23 The Trustees of The University of Pennsylvania Compstatin analogs with improved activity
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
EP1951279B1 (en) 2005-10-08 2017-04-12 Apellis Pharmaceuticals, Inc. Compstatin and analogs thereof for eye disorders
ES2390828T3 (es) 2005-11-28 2012-11-16 The Trustees Of The University Of Pennsylvania Análogos potentes de la compstatina
HUE026001T2 (en) 2007-02-05 2016-04-28 Apellis Pharmaceuticals Inc Compstatin analogues for use in the treatment of the inflammatory condition of the respiratory system
PT2424557T (pt) 2009-05-01 2018-02-05 Univ Pennsylvania Compstatina modificada com estrutura peptídica e modificações no terminal c
US20140113874A1 (en) 2010-09-23 2014-04-24 The Trustees Of The University Of Pennsylvania Modified Compstatin With Improved Stability And Binding Properties
JP2014503592A (ja) 2011-01-26 2014-02-13 ニコ ワールドワイド,インコーポレイテッド 片頭痛の療法
JP6522337B2 (ja) 2011-05-11 2019-05-29 アペリス・ファーマシューティカルズ・インコーポレイテッドApellis Pharmaceuticals,Inc. 細胞反応性、長時間作用型または標的化コンプスタチン類似体およびその使用
JP6618682B2 (ja) 2011-06-22 2019-12-11 アペリス・ファーマシューティカルズ・インコーポレイテッドApellis Pharmaceuticals,Inc. 補体阻害剤による慢性障害の治療方法
CN110229216B (zh) 2011-09-07 2023-06-16 宾夕法尼亚州大学理事会 具有改善的药代动力学性质的坎普他汀类肽
SI3660033T1 (sl) 2012-11-15 2021-09-30 Apellis Pharmaceuticals, Inc. Analogi kompstatina z dolgotrajnim delovanjem in sorodni sestavki in postopki
WO2014152391A1 (en) 2013-03-15 2014-09-25 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
US10213476B2 (en) 2014-03-17 2019-02-26 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
CA3001128A1 (en) 2015-10-07 2017-04-13 Apellis Pharmaceuticals, Inc. Use of long-acting compstatin analog for treating a complement-mediated eye disorder
JP2018534303A (ja) * 2015-11-12 2018-11-22 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク ポリミキシン系抗生物質に対する耐性グラム陰性細菌感染を標的にする合理的薬物設計
KR20190139931A (ko) 2017-04-07 2019-12-18 아펠리스 파마슈티컬스 인코포레이티드 투여 요법 및 관련 조성물 및 방법
CA3061340A1 (en) 2017-04-25 2018-11-01 Temple Otorongo Llc Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions
MX2020010520A (es) 2018-04-06 2021-01-15 Univ Pennsylvania Analogos de compstatina con mayor solubilidad y mejores propiedades farmacocineticas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055518B (it) * 1971-05-18 1982-01-11 Rotta Research Lab Derivatives del triptofano
US4482567A (en) * 1982-10-07 1984-11-13 Research Foundation For Mental Hygiene, Inc. N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics

Also Published As

Publication number Publication date
EP0237522B1 (en) 1993-02-24
IT8468241A1 (it) 1986-06-12
IT8468241A0 (it) 1984-12-12
DE3587122T2 (de) 1993-07-15
DK381486D0 (da) 1986-08-11
WO1986003489A1 (en) 1986-06-19
IE853029L (en) 1986-06-12
DK168564B1 (da) 1994-04-25
IT1179866B (it) 1987-09-16
ATE85976T1 (de) 1993-03-15
ES8706630A1 (es) 1987-06-01
AU5209986A (en) 1986-07-01
ZA859526B (en) 1986-08-27
PT81674A (en) 1986-01-01
EP0237522A1 (en) 1987-09-23
DE3587122D1 (de) 1993-04-01
US4870097A (en) 1989-09-26
DK381486A (da) 1986-08-11
CA1256441A (en) 1989-06-27
PT81674B (pt) 1987-10-20
JPS62501292A (ja) 1987-05-21
IE58502B1 (en) 1993-10-06
AU589938B2 (en) 1989-10-26

Similar Documents

Publication Publication Date Title
ES549822A0 (es) Procedimiento para la preparacion de derivados n-acilados del-triptofano
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ATE8874T1 (de) Therapeutisch nuetzliche 1-alkyl-2-amino-tetralin- derivate.
DK282488D0 (da) Farmaceutiske praeparater, deri indgaaende phenylalkylaminger eller salte deraf og forbindelsernes fremstilling
ES526896A0 (es) Procedimiento para la preparacion de b-carbolinas
MX169956B (es) Procedimiento para preparar p,p'-metilen-bis-anilinas substituidas
ES515081A0 (es) "procedimiento para la preparacion de derivados de 6-metilprednisolona".
ZA824438B (en) Novel 2-aryl-3,4-diazabicyclo-(4.n.o)alk-2-en-5-ones their preparation,and drugs containing them
EP0271013A3 (en) Basic substituted phenyl acetonitriles, their preparation and medicaments containing them
IL79910A (en) 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them
PT95990A (pt) Processo para a preparacao de novos derivados do tiofeno
EP0231003A3 (en) Basic substituted phenylacetonitriles, their preparation and medicaments containing them
PT77666A (fr) Procede de preparation de nouveaux derives de la nitrosouree
MX158073A (es) Procedimiento para preparar dipropilamino-2-hidroxi-6-formilamino-5-o-tetrahidro-1,2-3,4,-naftaleno
DK13280A (da) Fremgangsmaade til fremstilling af hexahydro-1,4-oxazepiner
ES550846A0 (es) Procedimiento para la obtencion de n-(fosfonometilglicil)sulfonilaminas de efecto herbicida.
PT84475B (pt) Processo para a preparacao de novos derivados da 1-stireno-sulfonil-2-oxo-5-hidroxi-pirrolidina
MX162589A (es) Procedimiento para preparar compuestos heterociclicos de 5 miembros conteniendo atomos de n,o o s
DE3362130D1 (en) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines, their preparation and use
SE7903233L (sv) Bensylidenestrar
SE8302084D0 (sv) New benzimidazole derivatives
MX11959A (es) Procedimiento de preparacion de nuevos derivados de 1-aril-sulfonil-1, 5-dihidro-2h-pirrol-2-ona y producto obtenido.
MX11977A (es) Derivados de 1-bencil-2-oxo-5-alcoxi-pirrolidina y procedimiento para su preparacion.
ATE17248T1 (de) N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung.
ATE46695T1 (de) Pyrimidinyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612